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Diagnosis of arrhythmogenic
right ventricular
cardiomyopathy: the role of
endomyocardial biopsy
guided by electroanatomic
voltage map
In the March, 2009, edition of Europace (volume
11, number 3), Ejima et al.1 reported the case of
a young woman in whom a diagnosis of arr-
hythmogenic right ventricular cardiomyopathy
(ARVC) was obtained with of a novel endo-
myocardial biopsy (EMB) approach, guided by
electroanatomic mapping of the right ventricle
(RV). In order to increase the diagnostic accu-
racy of EMB, Ejima et al.1 performed a biopsy
sampling focused on selected RV pathological
areas characterized by low-voltage potentials
(voltage mapping-guided EMB).
We share with Ejima et al. a great interest
for this innovative biopsy approach. Anyhow,
we would like to make some comments
regarding this “innovative strategy for per-
forming EMB . . . ”.
First, to the best of our knowledge, this
voltage-guided biopsy approach has been
described for the first time in 2007 by our
group in a report2 dealing with the case of a
young athlete with ARVC undetectable with
conventional diagnostic techniques.
Second, in 2008, we published3 the first
report assessing the feasibility of RV voltage
mapping-guided EMB in a series of 16
consecutive patients with a clinical evidence
or suspicion for ARVC. In the editorial
comment, accompanying our article, Hauer
and Cox4 particularly highlighted the impor-
tant diagnostic yield which the voltage-guided
EMB had provided above all in the early
stages of ARVC, often undetectable with con-
ventional standardized diagnostic criteria. Our
experience, for the most part reported in
several scientific sessions,5–8 has been
recently considered in a paper by Basso
et al.9 concerning an in vitro validation of diag-
nostic criteria for ARVC.
In comparison with the conventional
biopsy approach, voltage-guided EMB seems
to provide a greater sensitivity for obtaining
samples that are consistent with ARVC.
However, in order to verify the real
diagnostic accuracy of this innovative
approach, a prospective randomized study
comparing the non-targeted approach with
the voltage-guided approach seems necessary.
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Diagnosis of arrhythmogenic
right ventricular
cardiomyopathy: the role of
endomyocardial biopsy
guided by electroanatomic
voltage map: reply
We really appreciate Drs Avella, d’Amati, and
Tondo for their interest in our case report.1
We obviously share a common interest in
the research of endomyocardial biopsy
(EMB) guided by electroanatomical voltage
mapping and applaud their successful
approach and results.2,3
We had independently performed a similar
EMB approach on 6 August 2007, before their
case report was published.2 I would, however,
like to point out a difference in our research
that was published in 2009. In our present
case, we performed EMB not only for
making a correct diagnosis of arrhythmogenic
right ventricular cardiomyopathy, but also
applied this approach for therapeutic radio-
frequency catheter ablation for ventricular
tachycardia. We discussed this approach at a
local Japanese congress in January 2008 and
we are in agreement with Dr Avella et al.
that a prospective clinical study is necessary
to verify the diagnostic accuracy of this
method. We are thankful for the feedback
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